ACOR - Acorda Therapeutics receives Nasdaq extension to meet minimum bid price requirement
- Acorda Therapeutics ( NASDAQ: ACOR ) said the Nasdaq had granted extension request until June 20 to regain compliance with its minimum $1 bid price per share requirement.
- Press Release
For further details see:
Acorda Therapeutics receives Nasdaq extension to meet minimum bid price requirement